FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

370931002: Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug)

Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3762321010 Erythromycin ethyl succinate 200 mg chewable tablet en Synonym Active Case insensitive SNOMED CT core
3762322015 Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core
3762323013 Erythromycin ethylsuccinate 200 mg chewable tablet en Synonym Active Case insensitive SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin ethyl succinate 200 mg chewable tablet Has presentation strength denominator value 1 false Inferred relationship Some 1
Erythromycin ethyl succinate 200 mg chewable tablet Count of base of active ingredient 1 false Inferred relationship Some
Erythromycin ethyl succinate 200 mg chewable tablet Is a Erythromycin only product in oral dose form true Inferred relationship Some
Erythromycin ethyl succinate 200 mg chewable tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Erythromycin ethyl succinate 200 mg chewable tablet Has precise active ingredient Erythromycin ethylsuccinate true Inferred relationship Some 1
Erythromycin ethyl succinate 200 mg chewable tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Erythromycin ethyl succinate 200 mg chewable tablet Has unit of presentation Tablet true Inferred relationship Some
Erythromycin ethyl succinate 200 mg chewable tablet Has presentation strength numerator value 200 false Inferred relationship Some 1
Erythromycin ethyl succinate 200 mg chewable tablet Has BoSS Erythromycin ethylsuccinate true Inferred relationship Some 1
Erythromycin ethyl succinate 200 mg chewable tablet Plays role Antibacterial therapeutic role true Inferred relationship Some
Erythromycin ethyl succinate 200 mg chewable tablet Is a Erythromycin-containing product in oral dose form false Inferred relationship Some
Erythromycin ethyl succinate 200 mg chewable tablet Has active ingredient Erythromycin ethylsuccinate false Inferred relationship Some
Erythromycin ethyl succinate 200 mg chewable tablet Has manufactured dose form Tablet false Inferred relationship Some
Erythromycin ethyl succinate 200 mg chewable tablet Has active ingredient Bactericide false Inferred relationship Some
Erythromycin ethyl succinate 200 mg chewable tablet Has manufactured dose form Oral dose form false Inferred relationship Some
Erythromycin ethyl succinate 200 mg chewable tablet Is a Product containing erythromycin ethylsuccinate false Inferred relationship Some
Erythromycin ethyl succinate 200 mg chewable tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Some
Erythromycin ethyl succinate 200 mg chewable tablet Has manufactured dose form Conventional release chewable tablet true Inferred relationship Some
Erythromycin ethyl succinate 200 mg chewable tablet Is a Macrolide antibacterial agent false Inferred relationship Some
Erythromycin ethyl succinate 200 mg chewable tablet Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start